Medica SurB de CV (MEX:MEDICAB) Cyclically Adjusted Revenue per Share: MXN40.78 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:MEDICAB Medica Sur SAB de CV MEX:MEDICAB
82 GF Score
Price MXN59.50
GF Value MXN46.75
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Medica SurB de CV Cyclically Adjusted Revenue per Share?

Medica SurB de CV MEX:MEDICAB 82 Cyclically Adjusted Revenue per Share is MXN40.78 as of Dec. 2025. GuruFocus rates MEX:MEDICAB with a GF Score™ of 82/100 and a GF Value™ of MXN46.75 (Modestly Overvalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Medica SurB de CV's adjusted revenue per share for the three months ended in Dec. 2025 was MXN11.475. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is MXN40.78 for the trailing ten years ended in Dec. 2025.

During the past 12 months, Medica SurB de CV's average Cyclically Adjusted Revenue Growth Rate was 7.60% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 9.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Medica SurB de CV was 10.20% per year. The lowest was 6.90% per year. And the median was 8.70% per year.

As of today (2026-07-26), Medica SurB de CV's current stock price is MXN59.50. Medica SurB de CV's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2025 was MXN40.78. Medica SurB de CV's Cyclically Adjusted PS Ratio of today is 1.46.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Medica SurB de CV was 2.14. The lowest was 0.51. And the median was 1.19.


Medica SurB de CV  (MEX:MEDICAB) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Medica SurB de CV's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=59.50/40.78
=1.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Medica SurB de CV was 2.14. The lowest was 0.51. And the median was 1.19.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Medica SurB de CV Cyclically Adjusted Revenue per Share Related Terms


Medica SurB de CV Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Medica SurB de CV's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medica SurB de CV Cyclically Adjusted Revenue per Share Chart

Medica SurB de CV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.20 32.45 35.23 37.89 40.78

Medica SurB de CV Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.89 38.61 39.35 39.85 40.78

MEX:MEDICAB vs HCA, THC, DVA: Cyclically Adjusted Revenue per Share Comparison

For the Medical Care Facilities subindustry, Medica SurB de CV's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medica SurB de CV Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medica SurB de CV's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Medica SurB de CV's Cyclically Adjusted PS Ratio falls into.


MEX:MEDICAB
82GF Score
Medica Sur SAB de CV MEX:MEDICAB
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medica SurB de CV Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medica SurB de CV's adjusted Revenue per Share data for the three months ended in Dec. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=11.475/163.1900*163.1900
=11.475

Current CPI (Dec. 2025) = 163.1900.

Medica SurB de CV Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201603 6.282 102.573 9.994
201606 4.925 101.905 7.887
201609 4.692 103.084 7.428
201612 6.416 105.002 9.971
201703 7.099 108.063 10.720
201706 7.070 108.339 10.650
201709 6.821 109.628 10.154
201712 6.847 112.114 9.966
201803 7.187 113.505 10.333
201806 7.382 113.373 10.626
201809 7.504 115.130 10.636
201812 7.191 117.530 9.985
201903 7.398 118.050 10.227
201906 7.612 117.848 10.541
201909 7.537 118.581 10.372
201912 7.452 120.854 10.062
202003 7.519 121.885 10.067
202006 6.798 121.777 9.110
202009 10.009 123.341 13.243
202012 1.168 124.661 1.529
202103 7.242 127.574 9.264
202106 7.764 128.936 9.827
202109 8.464 130.742 10.565
202112 7.795 133.830 9.505
202203 8.946 137.082 10.650
202206 9.034 139.233 10.588
202209 9.341 142.116 10.726
202212 8.269 144.291 9.352
202303 9.834 146.472 10.956
202306 12.693 146.272 14.161
202309 9.056 148.446 9.955
202312 9.670 151.017 10.449
202403 9.742 152.947 10.394
202406 10.421 153.551 11.075
202409 10.060 155.246 10.575
202412 10.901 157.378 11.304
202503 11.004 158.761 11.311
202506 11.304 160.180 11.516
202509 10.507 161.030 10.648
202512 11.475 163.190 11.475

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of MXN40.78 mean?
Medica SurB de CV (MEX:MEDICAB) has a Cyclically Adjusted Revenue per Share of MXN40.78 as of Dec. 2025. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Medica SurB de CV and its competitors.
Is Medica SurB de CV's Cyclically Adjusted Revenue per Share too high?
Medica SurB de CV's current Cyclically Adjusted Revenue per Share is MXN40.78. Overall, Medica SurB de CV has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medica SurB de CV's Cyclically Adjusted Revenue per Share compare to HCA and THC?
Medica SurB de CV's Cyclically Adjusted Revenue per Share of MXN40.78 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Medica SurB de CV and its competitors. Medica SurB de CV's current Cyclically Adjusted Revenue per Share is MXN40.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medica SurB de CV stock overvalued right now?
Based on GuruFocus' analysis, Medica SurB de CV (MEX:MEDICAB) is currently considered Modestly Overvalued. The stock's GF Value™ is MXN46.75, compared to a current price of MXN59.50 — trading 27.3% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is MXN40.78. Medica SurB de CV's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Medica SurB de CV (MEX:MEDICAB), the current Cyclically Adjusted Revenue per Share is MXN40.78 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medica SurB de CV (MEX:MEDICAB) Overvalued in 2026?

Based on GuruFocus' analysis, Medica SurB de CV stock appears to be overvalued. The current stock price of MXN59.50 is trading 27.3% above its estimated GF Value™ of MXN46.75. GuruFocus considers Medica SurB de CV to be Modestly Overvalued.

Key valuation signals for MEX:MEDICAB:

  • Cyclically Adjusted Revenue per Share: MXN40.78
  • GF Value™: MXN46.75 vs. price of MXN59.50 (27.3% above fair value)
  • GF Score™: 82/100 with 5 warning signs

No single metric tells the full story. See the MEX:MEDICAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medica SurB de CV Business Description

Address Puente de Piedra 150, Col. Toriello Guerra,Tlalpan, Mexico, DF, MEX, 14050
Medica Sur SAB de CV is a medical care company specializes in emergency scenarios. The company offers emergency ambulance transportation, air transportation and paramedic assistance.
82GF Score

Get the complete analysis for MEX:MEDICAB

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN59.50
Price
MXN46.75
GF Value